Skip to main content
SNAQ VS OMADA HEALTH

Population health, meal by meal.

Omada brings virtual care to millions through employers and payers. SNAQ brings RCT-backed nutrition AI to the meal level. Different layers of the same stack.

In short.

Omada Health is a public B2B-distributed virtual care company (NASDAQ: OMDA) for prediabetes, T2D, hypertension and MSK, recently launched 'Meal Map' with the OmadaSpark AI agent. SNAQ is an AI nutritionist with photo carb counting validated at 5.5 g mean absolute error, a personal glucose model, and an RCT in eClinicalMedicine. The two are more complementary than competitive: Omada owns employer distribution; SNAQ provides the meal-level intelligence underneath.

At a glance.

  • Omada is employer- or payer-funded, with 1M+ cumulative participants and 29+ peer-reviewed publications on behavioural and clinical outcomes.
  • Omada's Meal Map (2025) introduced nutrient-quality coloring with the OmadaSpark AI agent. SNAQ photo carb counting is validated at 5.5 g mean absolute error in a peer-reviewed study.
  • SNAQ has a 2025 RCT specifically on Time-in-Range improvement (+6.6 pp) in T1D on AID. Omada's evidence centres on behavioural and weight outcomes.
  • Omada is US-only. SNAQ is global.
  • Omada is direct-to-employer; SNAQ is direct-to-consumer with a provider-facing option (SNAQ Care).

Feature by feature.

Structured comparison based on publicly available information, last reviewed May 2026.

Feature SNAQ Omada Health
Access model Direct-to-consumer + provider (SNAQ Care) Employer / payer / health-plan funded
Photo meal logging accuracy Validated at 5.5 g mean absolute carb error Meal Map nutrient categorisation, accuracy not peer-reviewed
Glucose prediction
Cohort coverage T1D, T2D, prediabetes, GLP-1 Prediabetes, T2D, hypertension, MSK, GLP-1
Peer-reviewed clinical evidence (product-specific) RCT 2025, eClinicalMedicine (TIR) 29+ studies on behavioural / weight outcomes
Geographic availability Global US only
Cost to member From $2.66/mo (3-year plan), 7-day free trial Free via employer / health plan
Best for Meal-level intelligence for diabetes and GLP-1 users Population-scale virtual care funded by employers / payers

Sources: Herzig D. et al., JMIR mHealth and uHealth, 2020 (carb counting accuracy) Piazza et al., eClinicalMedicine 2025 (RCT NCT05671679, Time-in-Range) SNAQ research overview Omada Health Meal Map launch, GlobeNewswire, October 2025 Omada Health product and outcomes pages

Why users switch.

01

If your employer doesn't offer Omada

Most US employees don't have Omada access today. SNAQ is available directly, no eligibility gate.

02

Meal-level intelligence

Omada's strength is behavioural curriculum and human coaching at population scale. SNAQ's strength is what to do at this meal, right now.

03

RCT evidence across cohorts

Omada's evidence base is largely behavioural and outcomes-based across prediabetes, T2D and adjacent conditions. SNAQ's published RCT (eClinicalMedicine 2025) measured Time-in-Range in T1D adults on automated insulin delivery, demonstrating nutrition-support outcomes a behavioural-curriculum program is not designed to capture.

Honest take.

Choose SNAQ if…

  • Your employer doesn't offer Omada, or you're outside the US.
  • You have T1D, T2D, prediabetes or take a GLP-1, and want a meal-AI tool.
  • You want meal-level intelligence in addition to (or instead of) a structured curriculum.

Consider Omada Health if…

  • Your employer or health plan funds Omada and you want a structured cohort program.
  • You want a longer-form curriculum and human coaching as the primary intervention.

Bottom line

Omada is the gold standard for employer-funded virtual care. SNAQ is the meal-AI layer most virtual care programs lack. Often complements rather than competes.

Published Clinical Evidence
+6.6%
Time in Range · eClinicalMedicine · 2025 · RCT

Published randomised controlled trial evidence, measured against standard care in T1D patients on automated insulin delivery systems.

Source: eClinicalMedicine (The Lancet), 2025 · Piazza et al. · NCT05671679

From a Omada Health user who switched.

★★★★★
Our employer's Omada program got me started. SNAQ is what I use day-to-day to actually decide what to eat.
Sasha L., prediabetes

Frequently asked.

What's the main difference between SNAQ and Omada Health?
SNAQ is an AI nutritionist built around photo carb counting, predictive glucose response, and peer-reviewed clinical evidence (RCT published in eClinicalMedicine in 2025). Omada Health solves a different problem in the same broader category. The right pick depends on whether your priority is general logging or clinically-validated nutrition guidance for diabetes, prediabetes or GLP-1 use.
Is the clinical evidence for SNAQ independently verified?
Yes. The primary randomised controlled trial (NCT05671679) was published in eClinicalMedicine, a peer-reviewed Lancet journal, in 2025. Photo carb counting accuracy was independently validated by Bern University Hospital and published in JMIR mHealth in 2020 (Herzig et al.).
Which CGMs and devices does SNAQ work with?
SNAQ integrates with 20+ devices including Dexcom (G6, G7, Stelo), FreeStyle Libre, Eversense, Apple Watch, Whoop, Garmin, Withings, Samsung Health, OneDrop and OneTouch. You bring whichever sensor or wearable you already use.
Can I use SNAQ alongside an Omada program?
Yes. The two tools sit at different layers. Omada provides structured cohort coaching and curriculum, often through your employer. SNAQ provides meal-level guidance with photo carb counting and a glucose model.
Does Omada have a meal-AI feature?
Omada launched Meal Map in 2025, a nutrient-quality categorisation tool powered by the OmadaSpark AI agent. The product centres on nutrient quality rather than carb-counting accuracy, and is not benchmarked against lab-verified meals in published sources.
Free to try

See the difference yourself.

No logbook can coach you. Download SNAQ free and find out what your data has been trying to tell you.

4.6 · 3,000+ App Store ratings
Get the app